Amgen Inc. NASDAQAMGN said the European Commission approved an MAA for Repatha evolocumab to treat several groups of patients with high cholesterol. The approval is the first anywhere for a PCSK9 inhibitor. Repatha is approved for adults with primary hyper...
↧